San Francisco, CANCT06319911Now EnrollingIRB Ready

Shoulder Osteoarthritis Clinical Trial in San Francisco, CA

Access cutting-edge shoulder osteoarthritis treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.

Sponsored by Smith & Nephew, Inc.

Quick Self-Assessment

See if you qualify for this San Francisco location

Preparing your pre-screening questions…

Expert Care in San Francisco

Access shoulder osteoarthritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related shoulder osteoarthritis treatment provided free

Apply for This San Francisco Location

Check if you qualify for this shoulder osteoarthritis clinical trial in San Francisco, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to San Francisco

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit San Francisco site if eligible
  4. 4Begin participation

About This Shoulder Osteoarthritis Study in San Francisco

The goal of this study is to confirm the safety and performance of the AETOS Shoulder System for USA adoption. This is a prospective, open, adaptive, non-comparative, multi-centre investigation enrolling a maximum of 220 subjects in 2 cohorts (anatomic and reverse) at up to 15 sites. No intra-study comparator group will be included, and there will be no randomization

Sponsor: Smith & Nephew, Inc.

Who Can Participate

Inclusion Criteria

Patients must meet all the following criteria to be included in the study:
Patient is at least 18 years of age at the time of consent and skeletally mature.
Patient is undergoing a primary elective anatomic or reverse shoulder replacement surgery for one of the following indications:
Rheumatoid arthritis, and/or
Traumatic arthritis (Post Traumatic arthritis), and/or
Non-inflammatory degenerative joint disease, and/or
Correction of functional deformity.
Patient is willing and able to accommodate all study-related procedures and visits detailed in the protocol \& cooperate in the standard of care post-operative therapy.
Patient is geographically stable and willing to return to the study site for all follow-up visits.
Patient has been adequately informed of risks and requirements of the study and is willing and able to provide informed consent for participation. \-

Exclusion Criteria

Patients who meet any of the following criteria will not qualify for participation in the trial:
Patient has a contraindication to AETOS.
Patient is undergoing a revision shoulder replacement surgery including total or partial arthroplasty.
Patient is indicated for a Hemiarthroplasty.
Patient has traumatic injury or a fracture.
Patient has uncontrolled diabetes with a hemoglobin A1C of 7.5 or greater.
Patient has comorbidities/conditions that preclude proper healing/fixation of the implant.
Patient has poor quality or insufficient bone stock to support the implant.
Patient has poor bone quality where there could be considerable migration of the implant and/or a chance of fracture.
Patient has rapid joint destruction, marked bone loss or bone resorption (e.g., severe osteoporosis).
Patient has osteomalacia.
Patient has muscular, neurologic, or vascular deficiencies that may compromise the outcome of the shoulder replacement surgery.
Patient has a known sensitivity, allergic reaction, and/or known allergies to one or more of the implanted materials.
Patient has a distant foci of infection which may spread to the implant site, active local or systemic infection, sepsis, or osteomyelitis.
Patient has an elevation of sedimentation rate, elevation of WBC count, or marked shift in WBC differential count unexplained by other disease.
If reverse shoulder arthroplasty, patient has a non-functional deltoid or external rotator muscles.
If reverse shoulder arthroplasty, patient has a significant injury to the upper brachial plexus.
If reverse shoulder arthroplasty, patient has paralysis of the axillary nerve.
Patient is uncooperative, has a neurologic disorder and is not capable of following directions, or is a vulnerable subject per ISO 14155 (i.e., individuals who are unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response).
Patient is pregnant or plans to become pregnant during the follow-up period.
Patient has a Body Mass Index (BMI) of \>35kg/m2 or a BMI that may compromise the outcome of the shoulder replacement surgery.
Patient has anticipated activities which would impose high stresses on the implant and its fixation or has a high likelihood of a fall.
Patient is a known smoker, vaper, alcohol abuser, or drug abuser within 180 days of consent.
Patient has participated previously in this clinical trial and was withdrawn.
Patient is participating in another device or drug trial or observational competitive study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in San Francisco?

Yes, this clinical trial (NCT06319911) has an active research site in San Francisco, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Shoulder Osteoarthritis Treatment Options in San Francisco, CA

If you're searching for shoulder osteoarthritis treatment options in San Francisco, CA, this clinical trial (NCT06319911) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced shoulder osteoarthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all shoulder osteoarthritis clinical trials near you to find additional studies recruiting in your area.

More Osteoarthritis Trials in San Francisco, CA

See all osteoarthritis clinical trials recruiting in San Francisco — not just this study.

Browse Osteoarthritis Trials in San Francisco →

Browse More Trials by Condition

Osteoarthritis TrialsAll Conditions →

Ready to Join in San Francisco?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · San Francisco, CA